For more than 40 years as a researcher and clinician, Joseph Broderick has actively contributed to improvements in stroke care, occupying a front row seat to seismic innovations: the clinical trials that proved tPA as the first effective treatment for acute ischemic stroke in the 1990s, the seminal trials leading to mechanical removal of clots within the artery in the 2000s and most recently the FASTEST trial today testing what could be the first treatment to slow bleeding for spontaneous acute intracerebral hemorrhage (ICH).
This article was originally published on MedicalXpress.com
